Commercialization Obligation Clause Samples
A Commercialization Obligation clause requires a party, typically a licensee, to actively pursue the development and marketing of a product or technology covered by an agreement. This clause may specify milestones, minimum sales targets, or timelines for bringing a product to market, and can include reporting requirements to demonstrate ongoing efforts. Its core function is to ensure that the licensed technology or product is not left unused, thereby protecting the licensor’s interests and maximizing the potential for commercial success.
Commercialization Obligation. Licensee shall undertake to use commercially reasonable efforts with regard to commercialization of the Products.
Commercialization Obligation. 15 CONFIDENTIAL TREATMENT REQUEST
Commercialization Obligation. Subsequent to development of the Module, SMI agrees to use reasonable efforts to (a) obtain necessary regulatory approvals for the marketing and sale of the Module in the International Territory, in those countries in which it elects to commercially distribute the Module, (b) provide for commercial production of the Module and (c) diligently market the Module after receipt of the necessary regulatory approvals, including, but not limited to, listing the Module in all of SMI's standard price lists and promoting and selling the Module at a level of effort and expense similar to the levels devoted to SMI's own patient monitoring equipment.
Commercialization Obligation. 24 4.5 Regulatory Process.............................................................................24 4.6
Commercialization Obligation. Alliant shall use commercially reasonable efforts to develop and commercialize the Licensed Products in North America, which efforts shall include: (a) commercial launch of Orapred ODT within sixty (60) days after Regulatory Approval by the FDA; and (b) allocation of efforts and resources consistent with the resources allocated by Alliant to the development and commercialization of Alliant’s other products with comparable commercial opportunity in the marketplace. Alliant shall be responsible for all costs and expenses incurred by Alliant in the development and commercialization of the Licensed Products in North America.
Commercialization Obligation. In order to maintain the license granted ---------------------------- hereunder in force, Licensee shall use reasonable efforts and due diligence (i) to pursue research and development for Products, and (ii) to obtain and maintain necessary governmental approvals for the sale of Products, as promptly as is reasonably and commercially feasible, and (iii) thereafter to produce and sell reasonable quantities of such Products in worldwide markets. Licensee shall keep Licensor and SKCC generally informed as to Licensee's progress for such research, development, approvals, production and sale, including its efforts, if any, to sublicense Licensor Patent Rights and/or Future Patent Rights. Licensee shall deliver to Licensor and SKCC an annual written report and such other reports as Licensor or SKCC may reasonably request. In the event Licensor, SKCC and Licensee cannot agree upon any matter related to Licensee's commercialization obligations, the parties agree to utilize arbitration pursuant to Article 9 hereof in order to resolve the matter. If the arbitrator determines that Licensee has not complied with its obligations hereunder as to a particular Product or Products, and such default is not fully cured within six (6) months after the arbitrator's decision, then Licensor may terminate this Agreement as to said particular Product or Products.
Commercialization Obligation. ▇▇▇▇ will exercise Commercially Reasonable Efforts to Market the Product to customers in the Territory during the Term at its sole cost and expense in accordance with the terms of this Agreement and Applicable Laws. Such efforts shall include the Launch of the Product, the preparation and delivery to CATALYST of: (i) an annual marketing plan for the Product (the first of which shall be delivered prior to the Launch Date); and (ii) sales projections for the Product on an annual basis. ▇▇▇▇ will provide CATALYST an opportunity to comment on such annual marketing plans, and will consider CATALYST’s comments in good faith, but the final marketing plan shall be determined by ▇▇▇▇ subject to complying with the other terms and conditions of this Agreement.